Central serous retinopathy: update on disease understanding and treatment

With ongoing extensive research on the disease process of CSR and a more nuanced understanding of the factors that increase risk of disease, observation remains the mainstay of management for acute CSR. For chronic CSR, PDT, laser, or anti-VEGF may be considered, with advances in imaging allowing OCTA to be a less invasive alternative method to dye angiography for detecting neovascularization.